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SUMMARY 
We previously found that TCF7L2 could activate the TMEPAI gene efficiently, 
whereas LEF1 could not nearly augment its transcription. When we 
comprehended the functional difference(s) between TCF7L2 and LEF1 with 
respect to the activation of the TMEPAI gene, the C-terminal tail of TCF7L2 was 
needed to reveal its transcriptional activity as well as its interaction with Smad3. 
Consistently, both TCF7/TCF7L2 and LEF1/TCF7L2 chimeric proteins exhibited 
an activity similar to TCF7L2 in transcription and Smad3 binding in contrast with 
LEF1 and TCF7. Our data elaborated on the diverse activity among TCF/LEF 
family members with respect to the transcriptional regulation of the TMEPAI gene. 
Keywords: C-clamp, Smad3, TCF/LEF family, TGF-β, TMEPAI 
 3 
The Wnt signaling pathways play key roles in regulation of homeostasis during both 
embryogenesis and adult life. These pathways have also involved in stem cell 
maintenance and tissue renewal. Thus, dysregulation of Wnt signal transduction is 
linked to embryonic defects and diseases such as cancer, fibrosis, and diabetes (1-5). 
The Wnt signaling pathways have been categorized as canonical and noncanonical 
pathways. The canonical pathway is mediated by β-catenin, which can interact with 
T-cell factor (TCF)/lymphoid enhance factor (LEF) family members in the nucleus, 
where the complex between β-catenin and TCF/LEF family members regulates Wnt 
target genes. On the other hand, the noncanonical pathway, which is alternatively 
termed the β-catenin-independent Wnt signaling pathway, triggers calcium efflux, 
ROCK activation, JNK phosphorylation to control cytoskeleton rearrangement, planar 
cell polarity, and transcriptional events (5). The TCF/LEF family, encompasses TCF7 
(also termed TCF1), TCF7L1 (also termed TCF3), TCF7L2 (also termed TCF4), and 
LEF1 (also termed TCF7L3) in mammals. There are four conserved regions in all 
TCF/LEFs: the β-catenin binding region in the N terminus, the high-mobility group 
(HMG) box in the middle region, the basic tail close to the HMG box, and the nuclear 
localization signal (NLS). The HMG box recognizes a specific DNA sequence, 
(C/G)TTT(C/G)(A/T)N(C/G), together with the basic tail to regulate Wnt/β-catenin 
 4 
target genes (1,3,5). Besides, some isoforms of the TCF/LEF family include the 
C-clamp in the C-terminal tail, which is known to act as the secondary DNA-binding 
domain. The C-clamp, whose four conserved cysteine residues are critical for its 
function, might target GC-rich sequences in the promoter regions of some genes (1,6-9).  
In a previous study, we showed that the TMEPAI gene is transcriptionally regulated by 
TCF7L2 which has a long C-terminal tail among the alternative splicing forms of 
TCF7L2. On the other hand, LEF1 could marginally activate the TMEPAI gene (10). 
Because both TCF7L2 and LEF1 can activate the Topflash reporter and interact with 
Smads (11,12), we explored in detail the mechanism by which TCF7L2, in contrast to 
LEF1, dramatically activates the TMEPAI gene.   
Previously, we did not examine the differences between TCF7L2- and LEF1-induced 
TMEPAI reporter activities upon TGF-β stimulation, although LEF1 had very marginal 
ability to activate the TMEPAI luciferase reporter as compared with TCF7L2 (10). 
Using the pGL3ti-850 luciferase reporter, whose activity can reflect the transcriptional 
activation of the TMEPAI gene upon TGF-β stimulation (10), we cotransfected either 
TCF7L2 or LEF1 in HepG2 cells and then subjected them to stimulation with TGF-β. 
As seen in Figure 1a, LEF1 could enhance the basal activity of this reporter slightly, 
whereas TGF-β did not potentiate LEF1-mediated reporter activity. Since LEF1 encodes 
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a shorter protein than TCF7L2, which has an extension of about 200 amino acids at its 
C terminus (termed the C-terminal tail) (Figure 1b), we postulated that a chimeric 
protein LEF1/TCF7L2 might recuperate the ability to activate the pGL3ti-850 reporter 
upon TGF-β stimulation (Figure 1b). As expected, the LEF1/TCF7L2 enormously 
potentiated the basal reporter activity of pGL3ti-850. Moreover, TGF-β further 
augmented this reporter activity enhanced by LEF1/TCF7L2. When we checked the 
abilities of the other two TCF/LEF family members, TCF7 and TCF7L1, to activate the 
pGL3ti-850 reporter, neither one influenced its activity, even though the cells were 
stimulated with TGF-β (Figure 1c). Since TCF7L1 also possesses a C-terminal extended 
region, which has no resemblance to the C-terminal tail of TCF7L2, we speculated that 
the C-terminal tail of TCF7L2 might provide TCF7L2 with the ability to activate the 
pGL3ti-850 reporter. The TCF7 isoform, which does not possess the long C-terminal 
region of the alternative splicing forms of TCF7, was also fused with the C-terminal tail 
of TCF7L2 (TCF7/TCF7L2) (Figure 1b) for investigation of the activity of the 
pGL3ti-850 reporter. Unlike TCF7, the chimeric protein TCF7/TCF7L2 could activate 
this reporter upon TGF-β stimulation (Figure 1c). It has been reported that the 
alternative splicing form of TCF7 (termed TCF7E), which, like TCF7L2, possesses a 
C-terminal long tail including the C-clamp, potentiates the activity of LOPtk reporter 
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which includes three copies of E-tail-requiring WREs (Wnt response elements) from the 
LEF1 promoter instead of three repeats of typical TCF/LEF WREs. That report also 
showed that the fusion of TCF7E’s C-terminal long tail with LEF1 emerges as a 
transcriptional activator of the LOPtk reporter, although LEF1 loses this activity (7). To 
confirm that the C-terminal tail of TCF7L2 displays its competence to mediate the 
activation of the pGL3ti-850 reporter, we made two mutants, TCF7L2∆C and 
TCF7L2(C463A) (Figure 1b). Both mutants lost the ability to activate the pGL3ti-850 
reporter. Thus, we concluded that the C-clamp in the C-terminal tail of TCF7L2 is 
necessary for TCF7L2 to potentiate pGL3ti-850 reporter activity upon TGF-β 
stimulation (Figure 1c). The possible abilities required by the C-terminal tail of TCF7L2 
for activation of the pGL3ti-850 reporter are as follows: DNA binding, interaction with 
Smad3, or transcriptional activation. When we fused TCF7L2 to the Gal4 DNA binding 
domain (Gal4 DBD), we could observe marginal transactivation of the reporter gene 
composed of the Gal4-DNA binding sequence although TGF-β stimulation inhibited its 
action. In contrast, the Gal4 DBD fusion protein with the C-clamp or the 
C-clamp(C463A) of TCF7L2 suppressed the basal reporter activity. Thus, it is highly 
possible that the C-clamp in TCF7L2 does not possess any ability for transcriptional 
activation (Figure 2). This evidence is consistent with notion that the N-terminal domain 
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of TCF/LEF family members plays an important role in the activation of canonical Wnt 
target genes via its association with β-catenin which recruits CBP/p300 (5).  
All the TCF/LEF family members are known to bind to specific DNA sequences 
recognized by their HMG DNA-binding domain (HMG DBD), which consists of both 
its HMG box and its basic tail. Additionally, the C-clamp in the splicing variants of 
TCF7 and TCF7L2 acts as the secondary DNA binding region that preferentially 
recognizes GC-rich sequences (1,5). Since TCF7L2 is known to bind to 
TGF-β-responsive TCF7L2-binding element (TTE) within the enhancer of the TMEPAI 
gene in TGF-β-induced TMEPAI activation, TTE is a critical cis-element for TGF-β to 
potentiate the transcription of TMEPAI together with Smad3 (10). Thus, we examined if 
the C-terminal tail of TCF7L2 binds to TTE. However, we could not observe any 
differences between the TCF/LEF family members and their mutants in terms of 
binding to TTE when a DNA affinity precipitation (DNAP) assay was carried out 
(Figure 3a). Therefore, the C-terminal tail of TCF7L2 is not needed for TCF7L2 to bind 
to TTE. These results are not surprising because the examined TCF/LEF family 
members and their mutants possess HMG DBD in their structures (Figure 1b). 
TCF7L2 has already been shown to bind to Smad3 (10,13,14). Thus, we examined the 
interaction of Smad3 with TCF/LEF family members and their mutants. Since we have 
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already shown that the Smad3 MH2 domain is involved in the interaction between 
Smad3 and TCF7L2 (10), we used GST-Smad3 MH2 to pull down the TCF/LEF family 
members and their mutants expressed in COS7 cells. As seen in Figure 3b, TCF7L2 and 
TCF7L2(C463A) could interact with Smad3 MH2, whereas the interaction of 
TCF7L2∆C with Smad3 MH2 was reduced. Curiously, both TCF7L2(C463A) and 
TCF7L2∆C could not activate the reporter activity (Fig. 1c) in spite of that both of them 
still bound to Smad3. It is possible that other transcriptional factor(s) and/or co-factor(s) 
might be needed for TCF7L2 to activate the TMEPAI gene together with Smad3 via its 
C-terminal region (or its C-clamp). This possibility will need to be examined in future. 
Although interaction between LEF1 and Smad3 MH2 could marginally be detected, 
LEF1/TCF7L2 revealed the ability to associate with Smad3 MH2 obviously. 
Additionally, fusion of the C-terminal tail of TCF7L2 to TCF7 (TCF7/TCF7L2), but not 
TCF7, exhibited the ability to interact with Smad3 MH2. These results indicate that the 
C-terminal tail of TCF7L2 is critical for TCF7L2 to associate with Smad3, although its 
C-clamp is not required for this association. 
In conclusion, we found that the C-clamp within TCF7L2 is needed for activation of the 
TMEPAI gene. However, its interaction domain with Smad3 lies in the region of the 
C-terminal tail other than the C-clamp. We suppose that the mutation of the C-clamp 
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might lead TCF7L2 to a conformational change by which it loses its ability of 
transcriptional activation. To confirm this, we need to conduct further experiments. 
TCF7L2, but not LEF1, can efficiently activate the TMEPAI gene together with the 
TGF-β/Smad3 signaling pathway. The current evidence indicates that interplay between 
the TCF/LEF family and Smad3 regulates the fine-tuning of TGF-β signaling via 
TMEPAI expression. We are continuing to investigate the importance of the 
TGF-β-mediated TMEPAI gene by TCF/LEF. 
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Figure legends 
Fig.1 Requirement of C-terminal tail of TCF7L2 for activation of the TMEPAI 
gene. (a) TCF7L2, but not LEF1, can enhance TGF-β-induced TMEPAI reporter 
activity. Either TCF7L2 or LEF1 was transfected in HepG2 cells with pGL3ti850 (15) 
and pCH110 (GE Healthcare) according to Nakano et al (10). (b) Structures of the 
examined TCF/LEF family members and their mutants. LEF1/TCF7L2 and 
TCF7/TCF7L2 were constructed by fusion of LEF1 and TCF7 with TCF7L2 (from Q411 
to E596), respectively. TCF7L2∆C consisted of TCF7L2 lacking the region from Q411 to 
E596. TCF7L2(C463A) indicates replacement of the fourth C463 into A in the C-clamp of 
TCF7L2. HMG DBD, HMG DNA binding domain; NLS, nuclear localization signal. (c) 
Effect of TCF/LEF and its mutants on TGF-β-mediated TMEPAI reporter activity. Each 
expression plasmid was transfected in HepG2 cells with (CAGA)12-luc and pCH110 
according to Nakano et al (10). To observe the protein expression for each construct, 
Western blot analysis was performed with anti-HA (3F10) antibody (Roche) according 
to Nakano et al (10). 
 
Fig. 2 The C-clamp is not required for TCF7L2 to activate the TMEPAI reporter. 
HepG2 cells were transfected with Gal4-TATA-Luc (Promega), and either Gal4 DBD 
(DNA binding domain) alone (Gal4) (16), Gal4 DBD-TCF7L2, Gal4 DBD-C-clamp or 
 15 
Gal4-DBD-C-clamp(C463A) according to Itoh et al (17). Gal4 DBD-C-clamp and Gal4 
DBD-C-clamp(C463A) were constructed by fusion of Gal4-DBD with TCF7L2 (from 
Q411 to E596) or TCF7L2(C463A) (from Q411 to E596), respectively. 
 
Fig. 3 Interaction of C-terminal tail of TCF7L2 with Smad3. (a) Ability of TCF/LEF 
family members and their mutants to bind to DNA. DNA affinity precipitation (DNAP) 
was performed according to our previous report (10). Protein binding to DNA using rat 
anti-HA antibody (3F10) was detected (upper panel). The expression of TCF/LEF 
family members and their mutants using rat anti-HA antibody (3F10) was measured 
(lower panel). (b) Interaction of Smad3 MH2 with TCF/LEF family members and their 
mutants. Using GST-Smad3 MH2 (upper and 2nd panels) and GST alone (3rd panel), 
the pulldown assay was carried out (17). Upper and 2nd panels show photos exposed for 
short and long terms, respectively. Total expression of TCF/LEF family members and 
their mutants was shown (lower panel).Western blot analysis was performed using rat 
anti-HA antibody (3F10). 
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